Company Filing History:
Years Active: 2016
Title: Jurjan Aman: Innovator in Endothelial Barrier Dysfunction Treatment
Introduction
Jurjan Aman is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of endothelial barrier dysfunction, particularly through his innovative patent that addresses inflammatory edema.
Latest Patents
Aman holds a patent titled "Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (ARG)." This invention focuses on new methods for treating endothelial barrier dysfunction by inhibiting the Abl-related gene (ARG). His work is crucial in developing therapeutic strategies for conditions associated with inflammatory edema.
Career Highlights
Jurjan Aman is affiliated with the Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg. His role in this organization allows him to further his research and contribute to advancements in medical science.
Collaborations
Aman has collaborated with esteemed colleagues such as Geerten P Van Nieuw Amerongen and Anton Vonk Noordegraaf. These partnerships enhance the impact of his research and foster innovation in the field.
Conclusion
Jurjan Aman is a dedicated inventor whose work in endothelial barrier dysfunction is paving the way for new treatment methods. His contributions are vital for advancing medical research and improving patient care.